Cerora received today its first Notice of Allowance via its intellectual property counsel at BakerHostetler for its U.S. patent application 13/327,034 which supports the Company’s core technology using multiple modes of information to assess brain health. This represents an important milestone for the Company as the US Patent and Trademark Office (PTO) has affirmed the company’s belief that a novel, non-obvious, and useful invention was disclosed.
The Company continues to prosecute its patent portfolio here in the US and around the globe.